•  
  •  
  •  
  •  

2026-02-15 15:03:07

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • RBI grants approval for Bain Capital to acquire joint control in Manappuram Finance
  • Anupam Rasayan Delivers Strong Q3 FY26 Performance
  • Hind Rectifiers Posts Record Q3 FY26 Revenue
  • AvenuesAI Reports Record Q3 FY26 with 122% Revenue Growth
  • Vipul Organics Reports Solid Q3 FY26 Growth

Keywords Selected:  APY

Stock Report

  • Emcure expands weight management therapy access with Launch of Poviztra®
  • Aptus Pharma Ltd enters into Urology therapy segment
  • Regional Rural Banks, Bandhan Bank from Kolkata leads in pension funds subscribers
  • Jubilant Pharmova announces completion of USFDA audit of facility Located at Spokane, Washington, USA
  • EaseMyTrip unveils the Leap Year Travel Sale with unprecedented discounts on travel bookings
  • Venus Remedies consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines
  • Laurus Labs signs MOA with IIT Kanpur for novel gene therapy assets
  • Supriya Lifescience Limited receives CEP from EDQM for API
  • BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A
  • Gufic Biosciences enters into research collaboration with Selvax Pty Ltd
  • Laurus Labs acquires substantial minority stake in a CAR-T cell therapy company - ImmunoACT

Latest Post

  • RBI grants approval for Bain Capital to acquire joint control in Manappuram Finance
  • Anupam Rasayan Delivers Strong Q3 FY26 Performance
  • Hind Rectifiers Posts Record Q3 FY26 Revenue
  • AvenuesAI Reports Record Q3 FY26 with 122% Revenue Growth
  • Vipul Organics Reports Solid Q3 FY26 Growth


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025